FDA Adverse Event Malfunction Summary report: N

COBAS E 411 ANALYZER (RACK SYSTEM)

MDR report key: 20462508 · Received October 16, 2024

Report

Report Number
1823260-2024-02990
Event Type
Malfunction
Date Received
October 16, 2024
Date of Event
September 13, 2024
Report Date
December 30, 2024
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
UDI-DI
04015630924721
PMA / PMN Number
K961481
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SF
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

CORRECTION: THE PCT REAGENT LOT NUMBER WAS 755916. THE FT4 REAGENT LOT NUMBER WAS 767235. THE INVESTIGATION IS ONGOING.

Additional Manufacturer Narrative · 0

THE FIELD SERVICE ENGINEER (FSE) ADJUSTED THE RACK LOADER SAMPLE POSITION. THE INSTRUMENT WAS VERIFIED AND ALL CHECKS WERE PERFORMED SUCCESSFULLY. THE ROOT CAUSE WAS DUE TO INSUFFICIENT COMPONENT ADJUSTMENT. THE SERVICE ACTIONS PERFORMED BY THE FSE RESOLVED THE ISSUE. NO FURTHER ISSUES WERE REPORTED AFTERWARD.

Additional Manufacturer Narrative · 0

THE PCT REAGENT LOT NUMBER WAS 120820. THE EXPIRATION DATE WAS NOT PROVIDED. THE FT4 REAGENT LOT NUMBER WAS 105782. THE EXPIRATION DATE WAS NOT PROVIDED. ON 13-SEP-2024 AND 14-SEP-2024, THE FSE FOUND THAT THE RACK LOADER WAS SLIGHTLY SEPARATED FROM THE INSTRUMENT COMPROMISING THE RACK SAMPLING POSITION ADJUSTMENT. HE POSITIONED THE RACK LOADER BACK INTO PLACE. HE THEN RAN TEST SAMPLES AND THEY WERE ACCEPTABLE. HE CONFIRMED THAT THE INSTRUMENT WAS PERFORMING BACK WITHIN SPECIFICATIONS. NO FURTHER ISSUES WERE OBSERVED. THE CUSTOMER MENTIONED THAT THEY RECEIVED LLD ERRORS AGAIN. ON (B)(6) 2024, THE FSE REPLACED THE SAMPLE/REAGENT PULLEY TUBING AND VERIFIED THAT THE LLD PRINTED CIRCUIT BOARD (PCB) WAS POSITIONED PROPERLY. HE ALSO FOUND THAT THE LLD VOLTAGE ON THE SAMPLE/REAGENT PROBE WAS SLIGHTLY LOWER THAN EXPECTED AND HE ADJUSTED IT TO 0.74. THE FSE THEN CHECKED ALL ADJUSTMENTS AND THEY WERE ALL WITHIN SPECIFICATIONS. HE PERFORMED CALIBRATION, QC, AND RAN TEST SAMPLES AND THEY WERE ALL ACCEPTABLE. THE INVESTIGATION IS ONGOING.

Description of Event or Problem · 0

WE RECEIVED AN ALLEGATION ABOUT DISCREPANT RESULTS FOR 1 PATIENT SERUM/PLASMA SAMPLE TESTED FOR PROCALCITONIN (PCT) AND 1 PATIENT SERUM/PLASMA SAMPLE TESTED FOR FT4 ON A COBAS E411 IMMUNOASSAY ANALYZER (RACK SYSTEM). SAMPLE 1 (PATIENT 1) WAS TESTED FOR PCT: INITIAL RESULT: 0.104 NG/ML. REPEAT RESULT: 17.03 NG/ML. SAMPLE 2 (PATIENT 2) WAS TESTED FOR FT4: INITIAL RESULT: 51.51 PMOL/L. THIS RESULT WAS CONSIDERED ABOVE THE EXPECTED RANGE (11.90 PMOL/L TO 21.60 PMOL/L). THE SAMPLE WAS THEN REPEATED ON 14-SEP-2024 AND THE REPEAT RESULT WAS 17.82 PMOL/L. THE CUSTOMER MENTIONED THAT THEY RECEIVED LIQUID LEVEL DETECTION (LLD) ERRORS ON (B)(6) 2024. THE REPEAT RESULTS WERE OBTAINED AFTER THE FIELD SERVICE ENGINEER (FSE) VISITED THE CUSTOMER'S SITE ON (B)(6) 2024 AND PERFORMED TROUBLESHOOTING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2558935 COBAS E 411 ANALYZER (RACK SYSTEM) IMMUNOCHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS 04015630924721

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown